136 results
Page 2 of 7
8-K
EX-99.1
o25 7cu3u
16 Feb 22
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
4:53pm
8-K
EX-99.2
y0pll 1fx
3 Dec 21
Entry into a Material Definitive Agreement
4:07pm
424B5
x8xh5uckapzq
3 Dec 21
Prospectus supplement for primary offering
4:06pm
424B5
y5lp ykmv
30 Nov 21
Prospectus supplement for primary offering
5:12pm
8-K
EX-99.1
imkekfv2r659
30 Nov 21
ImmunoGen Announces Positive Top-Line Results from Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer
6:37am
8-K
EX-99.1
gyf7es5 chts
11 Jan 21
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
f8b7f 20zk2nykbyo
18 Dec 20
Other Events
4:16pm
424B5
i2jclz
23 Jan 20
Prospectus supplement for primary offering
4:05pm
424B5
khtec55rg2rvc8
22 Jan 20
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
7ztedlv3ii pu
13 Jan 20
Results of Operations and Financial Condition
6:07am